hair-ex991

SAN JOSE, CA and TORONTO, August 14, 2019 (GLOBE NEWSWIRE) – Restoration Robotics, Inc. (NASDAQ:HAIR), a global leader in robotic hair restoration, and Venus Concept Ltd. (“Venus Concept”), a privately-held global aesthetic technology leader, provided an update on their pending merger and Restoration Robotics announced today its financial results for the second quarter ended June 30, 2019. Venus Concept will separately announce preliminary unaudited second quarter and year-to-date results.

On March 15, 2019, Restoration Robotics and Venus Concept announced that they entered into a definitive merger agreement to combine the companies in an all-stock transaction. The transaction is expected to close in either September or October of 2019, subject to the satisfaction of customary closing conditions, including the approval by the stockholders of each of Restoration Robotics and Venus Concept and the receipt of all necessary regulatory approvals. Restoration Robotics filed an amended proxy statement/prospectus on Form S-4 on July 29, 2019 responding to the Securities and Exchange Commission (SEC) reviewer comments.

Restoration Robotics, Inc., is a medical device company developing and commercializing the ARTAS® and ARTAS iX™ Robotic Hair Restoration System. Revenue in the second quarter of 2019 was $2.9 million, a 47% decline from $5.5 million in the second quarter of 2018. Gross margin in the second quarter of 2019 was 42% compared to 54% in the second quarter of 2018. The change in gross margin for the second quarter was driven by excess inventory charge in the period. Net loss for the second quarter of 2019 was $(7.9) million, or $(0.19) per share, compared with a net loss of $(6.2) million, or $(0.21) per share, for the second quarter of 2018.

Statements made in this press release that are not statements of historical fact are forward-looking statements. Forward-looking statements are subject to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are commonly identified by words such as “would,” “may,” “expects,” “believes,” “plans,” “intends,” “projects” and other terms with similar meaning. Investors are cautioned that the forward-looking statements in this document are based on current beliefs, assumptions and expectations, speak only as of the date of this document and involve risks and uncertainties that could cause actual

results to differ materially from current expectations. Such statements, including our expectations regarding the timing of the merger closing are subject to certain known and unknown risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause actual results and other future events to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. Material factors that could cause actual results to differ materially from current expectations include, without limitation, the following: the progress of our commercialization, marketing and manufacturing capabilities; and the timing or likelihood of regulatory filings and approvals for ARTAS for use in transplanting of hair. These factors, together with those that are described in greater detail in our Quarterly Report on Form 10-Q for the first quarter of 2019 that was filed on May 15, 2019 and as amended on July 9, 2019, as well as any reports that we may file with the SEC in the future including our Quarterly Report on Form 10-Q for the second quarter of 2019, may cause our actual results, performance or achievements to differ materially and adversely from those anticipated or implied by our forward-looking statements. We expressly disclaim any obligation, except as required by law, or undertaking to update or revise any such forward-looking statements. We expressly disclaim any obligation, except as required by law, or undertaking to update or revise any such forward-looking statements.

Investor Contact
The Ruth Group
Carol Ruth/Kaitlyn Brosco
cruth@theruthgroup.com/kbrosco@theruthgroup.com

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2019			2018			2019			2018
Revenue	$	2,931		$	5,475		$	8,325		$	10,480
Cost of revenue		1,711			2,514			4,168			5,699
Gross profit		1,220			2,961			4,157			4,781
Operating expenses:
Sales and marketing		4,166			4,365			8,736			8,749
Research and development		1,481			2,153			2,969			4,278
General and administrative		1,574			1,617			3,566			3,968
Merger related expenses		1,057			—			2,558			—
Total operating expenses		8,278			8,135			17,829			16,995
Loss from operations		(7,058	)		(5,174	)		(13,672	)		(12,214	)
Other expense, net:
Interest expense		(816	)		(500	)		(1,582	)		(858	)
Other expense, net		(8	)		(559	)		(54	)		(579	)
Total other expense, net		(824	)		(1,059	)		(1,636	)		(1,437	)
Net loss before provision for income taxes		(7,882	)		(6,233	)		(15,308	)		(13,651	)
Provision for income taxes		10			11		24				24
Net loss attributable to common stockholders	$	(7,892	)	$	(6,244	)	$	(15,332	)	$	(13,675	)
Net loss per share attributable to common stockholders, basic and diluted	$	(0.19	)	$	(0.21	)	$	(0.38	)	$	(0.47	)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted		40,843,166			29,080,414			40,798,338			29,038,730

	June 30,			December 31,
	2019			2018
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$	9,717		$	16,122
Accounts receivable, net		4,364			6,569
Inventory		6,482			5,522
Prepaid expenses and other current assets		998			1,278
Total current assets		21,561			29,491
Property and equipment, net		1,400			1,299
Restricted cash		83			83
Other assets		131			100
TOTAL ASSETS	$	23,175		$	30,973
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
CURRENT LIABILITIES:
Accounts payable	$	5,905		$	3,815
Accrued compensation		1,504			1,771
Other accrued liabilities		1,988			2,337
Deferred revenue		1,259			1,407
Current portion of long-term debt, net		3,928			49
Total current liabilities		14,584			9,379
Other long-term liabilities		686			594
Related party convertible promissory notes		5,000			—
Long-term debt, net		15,887			19,418
TOTAL LIABILITIES		36,157			29,391
STOCKHOLDERS’ EQUITY (DEFICIT):
Convertible preferred stock, $0.0001 par value; 10,000,000 shares authorized, and no shares issued and outstanding as of June 30, 2019 and December 31, 2018	—			—
Common stock, $0.0001 par value; 300,000,000 shares authorized as of June 30, 2019 and December 31, 2018; 40,857,012 and 40,677,012 shares issued and outstanding as of June 30, 2019 and December 31, 2018, respectively		4			4
Additional paid-in capital		195,559			194,841
Accumulated other comprehensive loss		—			(50	)
Accumulated deficit		(208,545	)		(193,213	)
TOTAL STOCKHOLDERS’ EQUITY (DEFICIT)		(12,982	)		1,582
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)	$	23,175		$	30,973